-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Neurocrine Biosciences, Raises Price Target to $200

Benzinga·12/05/2025 16:51:17
Listen to the news
TD Cowen analyst Phil Nadeau maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Buy and raises the price target from $175 to $200.